| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 04/27/2006 | CA2584519A1 Method for modification of gamma-secretase activity through inhibition of fkbp13 |
| 04/27/2006 | CA2584512A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/27/2006 | CA2584504A1 Piperidines and related compounds for treatment of alzheimer's disease |
| 04/27/2006 | CA2584459A1 Modulation of neuroglia-derived bdnf in the treatment and prevention of pain |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584317A1 Pyrazole derivatives as phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2584209A1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof |
| 04/27/2006 | CA2583943A1 Novel curcumin analogues and uses thereof |
| 04/27/2006 | CA2583565A1 3,6-substituted 5-arylamino-1h-pyridine-2-one derivatives and related compounds as poly(adp-ribose)polymerase (parp) inhibitors in the treatment of tissue damage or disease causedby necrosis or apoptosis |
| 04/27/2006 | CA2583536A1 Cgrp receptor antagonists |
| 04/27/2006 | CA2583534A1 Cgrp receptor antagonists |
| 04/27/2006 | CA2583267A1 Novel b1 bradykinin receptor antagonists |
| 04/27/2006 | CA2583177A1 Compounds for nonsense suppression, and methods for their use |
| 04/27/2006 | CA2580976A1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-[4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide to inhibit the tyrosine kinase receptor c-fms |
| 04/27/2006 | CA2574518A1 Pharmaceutical composition and non dependence coffee comprising edible carboxylic acid and/or its acid salt and coffeine |
| 04/26/2006 | EP1650220A2 Anti-VEGF antibodies |
| 04/26/2006 | EP1650205A1 Cyclohexanecarboxylic acid compound |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650199A1 Sulfonamide derivative having isoxazole ring |
| 04/26/2006 | EP1650193A2 6-Phenylphenanthridines with PDE-IV inhibiting activity |
| 04/26/2006 | EP1650190A1 3-aryl-3-methyl-quinoline-2,4-diones, preparation method thereof and pharmaceutical composition containing same |
| 04/26/2006 | EP1650189A1 Benzylamine derivative |
| 04/26/2006 | EP1650183A1 (Benzyloxy-biphenyl) acetic acids and derivatives thereof and their use in therapy |
| 04/26/2006 | EP1650182A1 Branched carboxylic acid compound and use thereof |
| 04/26/2006 | EP1649862A1 Agent for preventing and curing pathological states associated with endorphin deficiency in organism |
| 04/26/2006 | EP1649849A2 Compositions for the treatment of Parkinson's disease containing a CB1 receptor antagonist and a product that activates the dopaminergic neurotransmission in the brain. |
| 04/26/2006 | EP1648904A1 N-sulfonylheterocyclopyrrolylalkylamine compounds as 5-hydroxytryptamine-6 ligands |
| 04/26/2006 | EP1648897A1 N- [3-(3-substituted-pyrazolo[1,5-a] pyrimidin-7-yl) phenyl]-sulfonamides, and compositions, and methods related thereto |
| 04/26/2006 | EP1648896A1 7-substituted 3-nitro-pyrazolo [1,5-a] pyrimidines |
| 04/26/2006 | EP1648893A1 Nicotine addiction reducing heteroaryl fused azapolycyclic compounds |
| 04/26/2006 | EP1648886A1 Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments |
| 04/26/2006 | EP1648885A1 Novel compounds |
| 04/26/2006 | EP1648882A1 3-fluoro-piperidines as nmda/nr2b antagonists |
| 04/26/2006 | EP1648873A2 Neuroprotective macrocylic compounds and methods for their use |
| 04/26/2006 | EP1648872A2 Aryl fused azapolycyclic compounds |
| 04/26/2006 | EP1648567A1 Perinatal hypoxic-ischemic brain damage treatment |
| 04/26/2006 | EP1648503A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 04/26/2006 | EP1648450A1 Medicaments containing derivatives of aryl (or heteroaryl) azolylcarbinols |
| 04/26/2006 | EP1648443A1 1-sulfonylindole derivatives, their preparation and their use as 5-ht6 ligands |
| 04/26/2006 | EP1648437A2 Sirt1 modulators for manipulating cell/organism lifespan/stress response |
| 04/26/2006 | EP1648436A1 Ambroxol for treating epilepsy |
| 04/26/2006 | EP1648433A1 Substituted 2-aminotetralin for the treatment of depression |
| 04/26/2006 | EP1648431A1 Novel use of a polyamine-poor composition for the production of a medical human food |
| 04/26/2006 | EP1648421A2 Orally dissolving films |
| 04/26/2006 | EP1534708B1 Purine derivatives and their use as antiproliferative agents |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1409485B1 Immunomodulating compounds |
| 04/26/2006 | EP1408953B1 Carbamate compounds for use in preventing or treating bipolar disorder |
| 04/26/2006 | EP1399144B1 Carbamate compounds for use in preventing or treating anxiety disorders |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | EP1361894B1 Use of a polyfunctional active substance mixture as an antagonist against harmful substances contained in tobacco smoke acting as a health protecting agent during smoking |
| 04/26/2006 | EP1320710B1 Drying method for selectively removing volatile components from wet coatings |
| 04/26/2006 | EP1303286B1 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/26/2006 | EP1255535B1 Controlled release pharmaceutical composition containing tramadol hydrochloride |
| 04/26/2006 | EP1244454B1 Use of 2-amino-3,4-dihydro-quinazolines for producing a medicament for treating or preventing diseases caused by ischaemic conditions |
| 04/26/2006 | EP1153922B1 Heterodiazinone derivatives |
| 04/26/2006 | EP1066036B1 Agents with serotonin-related activity for the treatment for sleep apnea |
| 04/26/2006 | EP0977562B8 Methods and compositions for delivery of taxanes |
| 04/26/2006 | CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764647A Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 04/26/2006 | CN1764462A T-type calcium channel blockers |
| 04/26/2006 | CN1764460A Method of treating cognitive decline due to sleep deprivation and stress |
| 04/26/2006 | CN1764453A Therapeutic formulation for mainly of diarrhea large intesitine irritation syndrome |
| 04/26/2006 | CN1764447A Use of tanshinone derivates as cholinesterase inhibitors in treating related diseases |
| 04/26/2006 | CN1763069A Gen-seng saponin Rg2 preparation method, its pharmaceutical composition and uses in pharmacy |
| 04/26/2006 | CN1762497A Method for improving study and memory capability |
| 04/26/2006 | CN1762495A Long acting sustained-release formulation containing dopamine-receptor stimulant medicine and its preparation process |
| 04/26/2006 | CN1762489A Tf-SOD conjugate and its preparation process |
| 04/26/2006 | CN1762486A Use of cerebrosid-kinin in preparation of medicine for preventing and treating peripheral nerve disease |
| 04/26/2006 | CN1762483A Quick acting drug for resisting mental disease |
| 04/26/2006 | CN1762417A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases, its preparation process and use |
| 04/26/2006 | CN1762406A Quality control method of ixeris sonchifolia injection |
| 04/26/2006 | CN1762396A Application of H. erectum subsp. Longisepalum in preparation of health caring food |
| 04/26/2006 | CN1762395A Application of H. hubeiense in preparation of heath caring food |
| 04/26/2006 | CN1762392A Coriolus versicolor zymolyte, its preparation method and use for adjuvant as alcoholic drink |
| 04/26/2006 | CN1762384A Bear gall pill formula and its preparation method |
| 04/26/2006 | CN1762368A Usage of ocotillol in preparation of medicine for treating or preventing senile dementia |
| 04/26/2006 | CN1762365A Beta-carotene clathrate and its preparation method |
| 04/26/2006 | CN1762349A Externally applied ointment of ketorolac tromethamine and its preparation method |
| 04/26/2006 | CN1762340A Composite tramadol hydrochloride formulation and preparation process thereof |
| 04/26/2006 | CN1762338A Treatment method of conduct disorder |
| 04/26/2006 | CN1762334A Medicinal cooling emulsions |
| 04/26/2006 | CN1253463C Novel hydroxyalkyl indolocarbazole derivatives, preparation method and pharmaceutical compositions containing same |
| 04/26/2006 | CN1253453C 1-aryl beta-carboline and thio-analog, their preparations and uses in medicines |
| 04/26/2006 | CN1253452C Thioether subsituted imidazoquinoline compound |
| 04/26/2006 | CN1253451C Novel indodyl oxazole compound and its preparation and application |
| 04/26/2006 | CN1253449C Indolylmaleimide derivatives as protein kinase C inibitors |
| 04/26/2006 | CN1253435C Aryl oxime-piperazines useful as CCR5 antagonists |
| 04/26/2006 | CN1253201C Medicine for treating hemicrania |
| 04/26/2006 | CN1253167C Wild jujube kernel soup active part and its preparing process and new use |
| 04/25/2006 | US7034692 System and method for transparent early detection, warning, and intervention during a medical procedure |
| 04/25/2006 | US7034182 Compounds to treat Alzheimer's disease |
| 04/25/2006 | US7034176 Aminopropylphosphinic acids |
| 04/25/2006 | US7034153 Antidepressants; anxiolytic agents; eating disorders; antiulcer agents; drug abuse; Alzheimer's disease |
| 04/25/2006 | US7034141 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors |
| 04/25/2006 | US7034118 Isolation nucleic acids; genetic engineering |